10/10 Many thanks to all contributors from @TheHassanLab, @InstitutCerveau, our collaborators from Olivier Raineteau lab and funders (ANR NeoRepair & ANR NeoReGen, @France_SEP, BDL Capital Management)
1/10 Delighted that our study using pharmacogenomics to find compounds promoting oligodendrogenesis and repair in myelin pathologies is now published in Nat Communs, after 7 years of work! https://t.co/kaf1MTlukO (DOI: 10.1038/s41467-024-54003-9)
9/10 These findings support the repurposing of leucovorin and dyclonine for clinical trials targeting myelin disorders, offering potential therapeutic avenues for preterm brain injury and Multiple Sclerosis
We invite you to become member and register for free on the website https://t.co/ugG5TG3bRC, involving colleagues who may be interested in this initiative
Our latest paper out by @merbengochea@TheHassanLab about the numerical cognitive abilities of flies and the first evidence for the neurons required for this capacity in the visual system
Et si la maladie d’#Alzheimer imprimait sa marque chez l’embryon ? Des scientifiques de l’@InstitutCerveau (@inserm), montrent que la protéine précurseur de l’amyloïde (APP) possède un rôle biologique spécifique lors du neurodéveloppement.
https://t.co/0MSCizBaO6
@ShabaniDania @TheHassanLab@InstitutCerveau@ParisBrainInst paper on how the APP protein-famous for its role in Alzheimer’s disease- is actually a regulator of the tempo of human cortical development is now out in @ScienceAdvances
https://t.co/BjRgxbrzdx